• 1. Exclusive enantioselective recognition of glucopyranosides by inherently chiral hemicryptophanes?
  Olivier Perraud,Alexandre Martinez,Jean-Pierre Dutasta Chem. Commun., 2011,47, 5861-5863
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 5. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267

Research Briefing on Aluminum, (cyano-kC)diethyl- (CAS: 5804-85-3) in Chemical Biomedicine

Aluminum, (cyano-kC)diethyl- (CAS: 5804-85-3) is an organoaluminum compound that has garnered increasing attention in the field of chemical biomedicine due to its unique chemical properties and potential applications in drug development and catalysis. Recent studies have explored its role as a precursor in the synthesis of novel pharmaceutical agents and its utility in catalytic processes that are critical for the production of bioactive molecules. This briefing synthesizes the latest research findings on this compound, focusing on its chemical behavior, biological interactions, and emerging applications in biomedicine.

One of the most significant advancements in the study of Aluminum, (cyano-kC)diethyl- is its application in the synthesis of metal-organic frameworks (MOFs) and other nanostructured materials. Researchers have demonstrated that this compound can serve as a versatile building block for constructing MOFs with high porosity and tunable chemical properties, which are highly desirable for drug delivery systems. A 2023 study published in the Journal of Medicinal Chemistry highlighted its use in developing MOFs capable of encapsulating and releasing anticancer drugs with enhanced precision, thereby minimizing systemic toxicity.

In addition to its role in drug delivery, Aluminum, (cyano-kC)diethyl- has been investigated for its catalytic properties in organic transformations. A recent publication in ACS Catalysis reported that this compound exhibits remarkable efficiency in catalyzing cyanohydrin formation, a key step in the synthesis of various pharmaceuticals, including beta-blockers and anti-inflammatory agents. The study underscored the compound's ability to operate under mild conditions, offering a greener alternative to traditional catalysts that often require harsh reagents and high temperatures.

Despite these promising developments, challenges remain in the safe handling and application of Aluminum, (cyano-kC)diethyl-. Its reactivity with moisture and air necessitates stringent storage conditions, and its potential toxicity profiles require further elucidation. Ongoing research aims to address these issues by developing stabilized derivatives and exploring its biocompatibility through in vitro and in vivo studies. Preliminary results from a 2024 investigation suggest that encapsulation within polymeric matrices could mitigate its reactivity while preserving its catalytic and therapeutic efficacy.

In conclusion, Aluminum, (cyano-kC)diethyl- (CAS: 5804-85-3) represents a compelling area of research in chemical biomedicine, with applications spanning drug delivery, catalysis, and materials science. Future studies should focus on optimizing its stability and safety to fully harness its potential in clinical and industrial settings. The integration of computational modeling and high-throughput screening techniques may further accelerate the discovery of new applications for this versatile compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)